StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Noloon Nov 28, 2019 7:25pm

107 Views

Post# 30403986

RE:nolo

BlueChip9 wrote: You're not able to admit that you were wrong as a little teenager.

I really think you can't read. I've said it at least two times before that I would sell if things went south. And things went south. So I sold. That was my plan. Nothing secret about it. No surprises either. And now I'm moving on.

Selling a stock that's not performing as well as you thought it would IS admitting that you were wrong. And it is recognizing it.

What's more mature: selling when things are not working or having piles of worthless shares in your account? Keep both hands on the bag, Gordo. That's what you do best.

Adieu

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario